Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review
Journal of Clinical Medicine · 12.04.2023 · 12 (8) · 2833
DOI: 10.3390/jcm12082833 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.04.2023. Verfasst von Vincent Pham und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cochin Hospital, Hôpitaux Universitaire Paris Centre, Assistance Publique des Hôpitaux de Paris, 27 Rue du Faubourg Saint-J…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Stable coronary artery disease (CAD) has recently been replaced by a new entity described as chronic coronary syndrome (CCS). This new entity has been developed based on a better understanding of the pathogenesis, the clinical characteristics, and the morbi-mortality associated to this condition as part of the dynamic spectrum of CAD. This has significant implications in the clinical management of CCS patients, that ranges from lifestyle adaptation, medical therapy targeting all the elements contributing to CAD progression (i.e., platelet aggregation, coagulation, dyslipidaemia, and systemic inflammation), to invasive strategies (i.e., revascularization). CCS is the most frequent presentation of coronary artery disease which is the first cardiovascular disease worldwide. Medical therapy is the first line therapy for these patients; however, revascularization and especially percutaneous coronary intervention remains beneficial for some of them. European and American guidelines on myocardial revascularization were released in 2018 and 2021, respectively. These guidelines provide different scenarios to help physicians choose the optimal therapy for CCS patients. Recently, several trials focusing on CCS patients have been published. We sought to synthetize the place of revascularization in CCS patients according to the latest guidelines, the lessons learnt from recent trials on revascularization and medical therapy, and future perspectives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Cochin Hospital, Hôpitaux Universitaire Paris Centre, Assistance Publique des Hôpitaux de Paris, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France.
- Department of Cardiology, HartCentrum, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, 2020 Antwerp, Belgium.
- Faculté de Santé, Université Paris-Cité, 75006 Paris, France.
ORCID-Profile: Vincent Pham, Alice Moroni, Alice Benedetti
Zitieren
APA
Pham, V., Moroni, A., Gall, E., Benedetti, A., Zivelonghi, C., & Picard, F. (2023). Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review. Journal of Clinical Medicine, 12(8), 2833. https://doi.org/10.3390/jcm12082833
Vancouver
Pham V, Moroni A, Gall E, Benedetti A, Zivelonghi C, Picard F. Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review. Journal of Clinical Medicine. 2023;12(8):2833. doi:10.3390/jcm12082833
BibTeX
@article{Pham2023,
author = {Pham, Vincent and Moroni, Alice and Gall, Emmanuel and Benedetti, Alice and Zivelonghi, Carlo and Picard, Fabien},
title = {Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {8},
pages = {2833},
doi = {10.3390/jcm12082833}
}
EUVIMED